title: Classifying Africans with the metabolic syndrome.
abstract: This study was aimed to compare prevalences of the metabolic syndrome in Africans using five definitions as proposed by the World Health Organization (WHO), the European Group for the Study of Insulin Resistance (EGIR), the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults [Adult Treatment Panel (ATPIII)], the American College of Endocrinology (ACE), and the International Diabetes Federation (IDF). A further objective was to identify difficulties in classifying Africans with the metabolic syndrome and to suggest specific areas where criteria adjustments for identifying Africans should be made. A case-case-control cross-sectional study involved 102 urban African women. Except for microalbumin data, all data necessary for classification of the metabolic syndrome were collected, including fasting and 2-h glucose and insulin, anthropometric measurements, blood pressure, and lipids. The metabolic syndrome prevalences ranged from 5.4% (EGIR), 15.7% (ATPIII), >or=19.4% (WHO), 24.8% (IDF) to 25.5% (ACE). Only 2.9% (n=3) had a triglyceride level >or=1.69 mmol/l, but 58.8% (n=60) had a HDL-level <1.29 mmol/l, whereas 27% (n=26) were insulin resistant, 22.3% (n=21), had a blood pressure >or=140/90 or used hypertension medication. It seems as if the classification of hypertension, insulin resistance and hyperglycemia might have been adequate, but body composition and dyslipidemia criteria need adjustment for Africans. Since neither definition seems completely suitable for Africans it is suggested that clinical emphasis should rather be on treating any specific cardiovascular disease risk factor that is present, than on diagnosing a patient with the metabolic syndrome.
authors.affiliation: School for Physiology, Nutrition and Consumer Sciences, North-West University (Potchefstroom Campus), Potchefstroom, South Africa. Alta.Schutte@nwu.ac.za
authors.forename: A E
authors.initials: AE
authors.lastname: Schutte
authors.forename: R
authors.initials: R
authors.lastname: Schutte
authors.forename: H W
authors.initials: HW
authors.lastname: Huisman
authors.forename: J M van
authors.initials: JM
authors.lastname: Rooyen
authors.forename: L
authors.initials: L
authors.lastname: Malan
authors.forename: A
authors.initials: A
authors.lastname: Olckers
authors.forename: N T
authors.initials: NT
authors.lastname: Malan
mesh_terms: D000328:Adult; D000349:Africa / Q000453:epidemiology; D001786:Blood Glucose; D001794:Blood Pressure; D015992:Body Mass Index; D016022:Case-Control Studies; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance; D008055:Lipids / Q000097:blood; D024821:Metabolic Syndrome / Q000145:classification* / Q000175:diagnosis* / Q000453:epidemiology; D008875:Middle Aged; D055815:Young Adult
chemical_list: D001786:Blood Glucose; D007328:Insulin; D008055:Lipids